Gold
Compare Stocks
2 / 10Stock Comparison
DRD vs LIN
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
DRD vs LIN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Gold | Chemicals - Specialty |
| Market Cap | $2.52B | $232.56B |
| Revenue (TTM) | $15.96B | $34.66B |
| Net Income (TTM) | $4.82B | $7.13B |
| Gross Margin | 40.3% | 46.0% |
| Operating Margin | 25.1% | 28.8% |
| Forward P/E | 0.6x | 28.1x |
| Total Debt | $17M | $26.99B |
| Cash & Equiv. | $1.31B | $5.06B |
DRD vs LIN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| DRDGOLD Limited (DRD) | 100 | 298.6 | +198.6% |
| Linde plc (LIN) | 100 | 248.0 | +148.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DRD vs LIN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DRD carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 26.3%, EPS growth 68.2%, 3Y rev CAGR 15.5%
- 5.3% 10Y total return vs LIN's 376.9%
- Lower volatility, beta 0.52, Low D/E 0.2%, current ratio 2.28x
LIN is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 6 yrs, beta 0.24, yield 1.2%
- Beta 0.24, yield 1.2%, current ratio 0.88x
- Beta 0.24 vs DRD's 0.52
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 26.3% revenue growth vs LIN's 3.0% | |
| Value | Lower P/E (0.6x vs 28.1x) | |
| Quality / Margins | 30.2% margin vs LIN's 20.6% | |
| Stability / Safety | Beta 0.24 vs DRD's 0.52 | |
| Dividends | 1.2% yield, 6-year raise streak, vs DRD's 1.0% | |
| Momentum (1Y) | +95.1% vs LIN's +13.6% | |
| Efficiency (ROA) | 32.9% ROA vs LIN's 8.3%, ROIC 9.8% vs 11.3% |
DRD vs LIN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
DRD vs LIN — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — DRD and LIN each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LIN is the larger business by revenue, generating $34.7B annually — 2.2x DRD's $16.0B. DRD is the more profitable business, keeping 30.2% of every revenue dollar as net income compared to LIN's 20.6%. On growth, DRD holds the edge at +26.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $16.0B | $34.7B |
| EBITDAEarnings before interest/tax | $4.9B | $12.1B |
| Net IncomeAfter-tax profit | $4.8B | $7.1B |
| Free Cash FlowCash after capex | $1.1B | $5.1B |
| Gross MarginGross profit ÷ Revenue | +40.3% | +46.0% |
| Operating MarginEBIT ÷ Revenue | +25.1% | +28.8% |
| Net MarginNet income ÷ Revenue | +30.2% | +20.6% |
| FCF MarginFCF ÷ Revenue | +6.8% | +14.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +26.6% | +8.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +89.0% | +13.4% |
Valuation Metrics
DRD leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 18.6x trailing earnings, DRD trades at a 46% valuation discount to LIN's 34.4x P/E. On an enterprise value basis, LIN's 20.0x EV/EBITDA is more attractive than DRD's 29.4x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $2.5B | $232.6B |
| Enterprise ValueMkt cap + debt − cash | $2.4B | $254.5B |
| Trailing P/EPrice ÷ TTM EPS | 18.60x | 34.40x |
| Forward P/EPrice ÷ next-FY EPS est. | 0.63x | 28.12x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.36x |
| EV / EBITDAEnterprise value multiple | 29.36x | 20.04x |
| Price / SalesMarket cap ÷ Revenue | 5.29x | 6.84x |
| Price / BookPrice ÷ Book value/share | 4.70x | 5.92x |
| Price / FCFMarket cap ÷ FCF | 33.19x | 45.70x |
Profitability & Efficiency
DRD leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
DRD delivers a 44.8% return on equity — every $100 of shareholder capital generates $45 in annual profit, vs $18 for LIN. DRD carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to LIN's 0.68x. On the Piotroski fundamental quality scale (0–9), DRD scores 7/9 vs LIN's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +44.8% | +17.8% |
| ROA (TTM)Return on assets | +32.9% | +8.3% |
| ROICReturn on invested capital | +9.8% | +11.3% |
| ROCEReturn on capital employed | +9.3% | +13.0% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 6 |
| Debt / EquityFinancial leverage | 0.00x | 0.68x |
| Net DebtTotal debt minus cash | -$1.3B | $21.9B |
| Cash & Equiv.Liquid assets | $1.3B | $5.1B |
| Total DebtShort + long-term debt | $17M | $27.0B |
| Interest CoverageEBIT ÷ Interest expense | 274.61x | 34.52x |
Total Returns (Dividends Reinvested)
DRD leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DRD five years ago would be worth $29,493 today (with dividends reinvested), compared to $17,813 for LIN. Over the past 12 months, DRD leads with a +95.1% total return vs LIN's +13.6%. The 3-year compound annual growth rate (CAGR) favors DRD at 31.6% vs LIN's 12.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -2.8% | +17.3% |
| 1-Year ReturnPast 12 months | +95.1% | +13.6% |
| 3-Year ReturnCumulative with dividends | +128.0% | +41.9% |
| 5-Year ReturnCumulative with dividends | +194.9% | +78.1% |
| 10-Year ReturnCumulative with dividends | +527.0% | +376.9% |
| CAGR (3Y)Annualised 3-year return | +31.6% | +12.4% |
Risk & Volatility
LIN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
LIN is the less volatile stock with a 0.24 beta — it tends to amplify market swings less than DRD's 0.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LIN currently trades 96.3% from its 52-week high vs DRD's 74.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.52x | 0.24x |
| 52-Week HighHighest price in past year | $39.37 | $521.28 |
| 52-Week LowLowest price in past year | $12.75 | $387.78 |
| % of 52W HighCurrent price vs 52-week peak | +74.1% | +96.3% |
| RSI (14)Momentum oscillator 0–100 | 34.6 | 50.6 |
| Avg Volume (50D)Average daily shares traded | 292K | 2.3M |
Analyst Outlook
LIN leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates DRD as "Buy" and LIN as "Buy". Consensus price targets imply 59.4% upside for DRD (target: $47) vs 7.5% for LIN (target: $540). For income investors, LIN offers the higher dividend yield at 1.20% vs DRD's 1.03%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $46.50 | $539.71 |
| # AnalystsCovering analysts | 5 | 28 |
| Dividend YieldAnnual dividend ÷ price | +1.0% | +1.2% |
| Dividend StreakConsecutive years of raises | 0 | 6 |
| Dividend / ShareAnnual DPS | $4.97 | $6.00 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.0% |
DRD leads in 3 of 6 categories (Valuation Metrics, Profitability & Efficiency). LIN leads in 2 (Risk & Volatility, Analyst Outlook). 1 tied.
DRD vs LIN: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is DRD or LIN a better buy right now?
For growth investors, DRDGOLD Limited (DRD) is the stronger pick with 26.
3% revenue growth year-over-year, versus 3. 0% for Linde plc (LIN). DRDGOLD Limited (DRD) offers the better valuation at 18. 6x trailing P/E (0. 6x forward), making it the more compelling value choice. Analysts rate DRDGOLD Limited (DRD) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DRD or LIN?
On trailing P/E, DRDGOLD Limited (DRD) is the cheapest at 18.
6x versus Linde plc at 34. 4x. On forward P/E, DRDGOLD Limited is actually cheaper at 0. 6x.
03Which is the better long-term investment — DRD or LIN?
Over the past 5 years, DRDGOLD Limited (DRD) delivered a total return of +194.
9%, compared to +78. 1% for Linde plc (LIN). Over 10 years, the gap is even starker: DRD returned +527. 0% versus LIN's +376. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DRD or LIN?
By beta (market sensitivity over 5 years), Linde plc (LIN) is the lower-risk stock at 0.
24β versus DRDGOLD Limited's 0. 52β — meaning DRD is approximately 115% more volatile than LIN relative to the S&P 500. On balance sheet safety, DRDGOLD Limited (DRD) carries a lower debt/equity ratio of 0% versus 68% for Linde plc — giving it more financial flexibility in a downturn.
05Which is growing faster — DRD or LIN?
By revenue growth (latest reported year), DRDGOLD Limited (DRD) is pulling ahead at 26.
3% versus 3. 0% for Linde plc (LIN). On earnings-per-share growth, the picture is similar: DRDGOLD Limited grew EPS 68. 2% year-over-year, compared to 7. 1% for Linde plc. Over a 3-year CAGR, DRD leads at 15. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DRD or LIN?
DRDGOLD Limited (DRD) is the more profitable company, earning 28.
5% net margin versus 20. 3% for Linde plc — meaning it keeps 28. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LIN leads at 26. 3% versus 11. 6% for DRD. At the gross margin level — before operating expenses — LIN leads at 43. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DRD or LIN more undervalued right now?
On forward earnings alone, DRDGOLD Limited (DRD) trades at 0.
6x forward P/E versus 28. 1x for Linde plc — 27. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DRD: 59. 4% to $46. 50.
08Which pays a better dividend — DRD or LIN?
All stocks in this comparison pay dividends.
Linde plc (LIN) offers the highest yield at 1. 2%, versus 1. 0% for DRDGOLD Limited (DRD).
09Is DRD or LIN better for a retirement portfolio?
For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
24), 1. 2% yield, +376. 9% 10Y return). Both have compounded well over 10 years (LIN: +376. 9%, DRD: +527. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DRD and LIN?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: DRD is a small-cap high-growth stock; LIN is a large-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.